1,4,9,10-tetrahydroxyanthracene,
leucoquinizarin,
Anthracene-1,4,9,10-tetraol,
476-60-8,
Leucoquinizarin,
1,4,9,10-Anthracenetetrol,
1,4,9,10-Tetrahydroxyanthracene,
1,4,9,10-Anthracenetetraol,
leuco-Quinizarin,
1,4-Dihydroxy-9,10-anthraquinol,
UNII-CP3E23813Z,
CCRIS 5594,
EINECS 207-507-8,
NSC 15369,
BRN 1582765,
anthracene-1,4,9,10-tetrol,
BKNBVEKCHVXGPH-UHFFFAOYSA-N,
CP3E23813Z,
NSC-15369,
Leucoquinzarine,
Leukochinizarin,
NSC15369,
AC1Q7AXX,
ACMC-1AMR4,
1,9,10-Anthracenetetrol,
AC1L28YE,
3-08-00-03706 (Beilstein Handbook Reference),
KSC235O8L,
SCHEMBL145008,
1,4-Dihydroxyanthrahydroquinone,
1,9,10-Tetrahydroxyanthracene,
DTXSID1060057,
CTK1D5785,
KS-000010IS,
1,4,9,10-Tetrahydroxy-anthracene,
6163AF,
ACM476608,
MFCD00058948,
ZINC18032052,
1,4-dihydrotachysterol(leucocompound),
AKOS016014231,
RTR-031208,
AJ-70234,
AK129327,
AN-45154,
LS-87926,
AX8054378,
FT-0627805,
2,3-Dihydro-9,10-dihydroxy-1,4-anthraquinone,
C-46330,
I14-56659,
C14H10O4,
KST-1B4581,
CID68063,
AR-1B7399,
C14-H10-O4,
T0116,
50553-66-7,